Science
Mechanism of Action
Anthraquinone operates by inhibiting MAPK and NF-κB signaling pathways, which effectively downregulates the production of pro-inflammatory cytokines such as IL-6, IL-8, and TNF-α. It further provides antioxidant benefits through free radical scavenging, though it possesses a dual nature where UV exposure can trigger the generation of singlet oxygen, leading to photo-oxidative DNA damage.
Research
Clinical Evidence
Medium confidence0.1%
Key findings
- 01 Topical 1% rhubarb-derived anthraquinones significantly reduced epidermal thickness and scaling in psoriasiform models via STAT3 inhibition (Biomedicine & Pharmacotherapy, 2021).
- 02 A 0.1% anthraquinone-rich fraction from Rubia cordifolia demonstrated significant antimicrobial efficacy against P. acnes and S. epidermidis (ResearchGate/Industrial Crops and Products, 2016).
Transparency
Dusting Analysis
Because safety standards limit this ingredient to 50 ppm (0.005%), any concentration high enough to achieve the 'clinical' results seen in studies (0.1%+) would exceed legal safety limits for leave-on cosmetics.
The Formula
Formulation
Stability
Highly susceptible to UV degradation; exposure can trigger phototoxic reactions. Stability is optimal in acidic environments and fails significantly above pH 6.0.
Conflicts
- Strong oxidizing agents
- Hydrogen peroxide
- Ferrous sulphate
- Alkaline environments (pH > 6.0)
Safety
Safety Profile
Classified by IARC as Group 2B (possibly carcinogenic). It is banned in California under Assembly Bill No. 496 (effective 2027) and restricted to 50 ppm in botanical extracts to prevent phototoxicity.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While it offers valid antimicrobial and anti-psoriatic benefits, the extreme risk of phototoxicity and its classification as a potential carcinogen make it inappropriate for modern skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…